NEW YORK (GenomeWeb) – Gen9 has signed a deal to supply synthetic DNA to renewable products firm Amyris, the companies announced today.

Under the terms of the agreement, Gen9 will provide Amyris with multiple megabases of synthetic DNA content for use in its microbial engineering pipeline. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.